Jason Bednar
Stock Analyst at Piper Sandler
(3.46)
# 1,029
Out of 4,496 analysts
136
Total ratings
46.32%
Success rate
5.03%
Average return
Main Sectors:
22 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COO The Cooper Companies | Maintains: Overweight | $115 | $90.75 | +26.72% | 10 | Jul 3, 2024 | |
| XAIR Beyond Air | Maintains: Overweight | $7 → $3.5 | $0.57 | +516.52% | 2 | Jun 25, 2024 | |
| HSIC Henry Schein | Reiterates: Overweight | $86 | $70.34 | +22.26% | 6 | Jun 21, 2024 | |
| ALGN Align Technology | Maintains: Overweight | $375 → $330 | $251.60 | +31.16% | 21 | Jun 21, 2024 | |
| MASI Masimo | Upgrades: Overweight | $126 → $160 | $106.76 | +49.87% | 10 | Jun 3, 2024 | |
| SHC Sotera Health Company | Initiates: Neutral | $13 | $13.09 | -0.69% | 1 | May 21, 2024 | |
| STE STERIS | Reiterates: Neutral | $220 → $225 | $224.29 | +0.32% | 7 | May 10, 2024 | |
| XRAY DENTSPLY SIRONA | Reiterates: Neutral | $35 → $32 | $26.36 | +21.40% | 6 | May 3, 2024 | |
| MMSI Merit Medical Systems | Maintains: Overweight | $95 → $97 | $85.49 | +13.46% | 5 | May 1, 2024 | |
| NVCR NovoCure | Reiterates: Overweight | $25 → $28 | $18.40 | +52.17% | 8 | Apr 10, 2024 | |
| LUNG Pulmonx | Reiterates: Overweight | $17 | $7.92 | +114.65% | 9 | Apr 3, 2024 | |
| DRTS Alpha Tau Medical | Reiterates: Overweight | $8 → $7 | $2.10 | +233.33% | 4 | Mar 8, 2024 | |
| MDXH MDxHealth | Maintains: Overweight | $6 → $7 | $2.80 | +150.00% | 4 | Mar 7, 2024 | |
| PDCO Patterson Companies | Downgrades: Neutral | $34 → $28 | $25.05 | +11.78% | 7 | Feb 29, 2024 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $310 → $372 | $455.01 | -18.24% | 4 | Jan 3, 2024 | |
| EDAP EDAP TMS | Maintains: Overweight | $14 → $9 | $5.10 | +76.47% | 2 | Nov 10, 2023 | |
| BDX Becton, Dickinson and Company | Maintains: Overweight | $305 → $280 | $230.74 | +21.35% | 6 | Nov 10, 2023 | |
| SONX Sonendo | Maintains: Neutral | $1 → $0.4 | $0.07 | +453.63% | 6 | Nov 9, 2023 | |
| VAPO Vapotherm | Maintains: Underweight | $2 → $1 | $2.15 | -53.49% | 6 | Nov 9, 2023 | |
| NVST Envista Holdings | Downgrades: Neutral | $39 → $25 | $16.57 | +50.88% | 8 | Nov 2, 2023 | |
| KRMD KORU Medical Systems | Maintains: Overweight | $4.5 → $3 | $2.52 | +19.05% | 3 | Aug 3, 2023 | |
| GEHC GE HealthCare Technologies | Initiates: Overweight | $95 | $80.44 | +18.10% | 1 | Apr 19, 2023 |
The Cooper Companies
Jul 3, 2024
Maintains: Overweight
Price Target: $115
Current: $90.75
Upside: +26.72%
Beyond Air
Jun 25, 2024
Maintains: Overweight
Price Target: $7 → $3.5
Current: $0.57
Upside: +516.52%
Henry Schein
Jun 21, 2024
Reiterates: Overweight
Price Target: $86
Current: $70.34
Upside: +22.26%
Align Technology
Jun 21, 2024
Maintains: Overweight
Price Target: $375 → $330
Current: $251.60
Upside: +31.16%
Masimo
Jun 3, 2024
Upgrades: Overweight
Price Target: $126 → $160
Current: $106.76
Upside: +49.87%
Sotera Health Company
May 21, 2024
Initiates: Neutral
Price Target: $13
Current: $13.09
Upside: -0.69%
STERIS
May 10, 2024
Reiterates: Neutral
Price Target: $220 → $225
Current: $224.29
Upside: +0.32%
DENTSPLY SIRONA
May 3, 2024
Reiterates: Neutral
Price Target: $35 → $32
Current: $26.36
Upside: +21.40%
Merit Medical Systems
May 1, 2024
Maintains: Overweight
Price Target: $95 → $97
Current: $85.49
Upside: +13.46%
NovoCure
Apr 10, 2024
Reiterates: Overweight
Price Target: $25 → $28
Current: $18.40
Upside: +52.17%
Pulmonx
Apr 3, 2024
Reiterates: Overweight
Price Target: $17
Current: $7.92
Upside: +114.65%
Alpha Tau Medical
Mar 8, 2024
Reiterates: Overweight
Price Target: $8 → $7
Current: $2.10
Upside: +233.33%
MDxHealth
Mar 7, 2024
Maintains: Overweight
Price Target: $6 → $7
Current: $2.80
Upside: +150.00%
Patterson Companies
Feb 29, 2024
Downgrades: Neutral
Price Target: $34 → $28
Current: $25.05
Upside: +11.78%
Intuitive Surgical
Jan 3, 2024
Maintains: Outperform
Price Target: $310 → $372
Current: $455.01
Upside: -18.24%
EDAP TMS
Nov 10, 2023
Maintains: Overweight
Price Target: $14 → $9
Current: $5.10
Upside: +76.47%
Becton, Dickinson and Company
Nov 10, 2023
Maintains: Overweight
Price Target: $305 → $280
Current: $230.74
Upside: +21.35%
Sonendo
Nov 9, 2023
Maintains: Neutral
Price Target: $1 → $0.4
Current: $0.07
Upside: +453.63%
Vapotherm
Nov 9, 2023
Maintains: Underweight
Price Target: $2 → $1
Current: $2.15
Upside: -53.49%
Envista Holdings
Nov 2, 2023
Downgrades: Neutral
Price Target: $39 → $25
Current: $16.57
Upside: +50.88%
KORU Medical Systems
Aug 3, 2023
Maintains: Overweight
Price Target: $4.5 → $3
Current: $2.52
Upside: +19.05%
GE HealthCare Technologies
Apr 19, 2023
Initiates: Overweight
Price Target: $95
Current: $80.44
Upside: +18.10%